• 1
    Australian Infection Control Association Expert Working Group. 2001 National Surveillance of Healthcare Associated Infection in Australia: A Report to the Commonwealth Department of Health and Aged Care.
  • 2
    Payne NR, Carpenter JH, Badger GJ, Horbar JD, Rogowski J. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Paediatrics 2004; 112: 348355.
  • 3
    Bryant KA, Zerr DM, Huskins WC, Milstone AM. Prevention in paediatrics: catheter-associated bloodstream infections. Infect. Control Hosp. Epidemiol. 2010; 31 (Suppl. 1): S2731.
  • 4
    Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect. Control Hosp. Epidemiol. 2010; 31: 846849.
  • 5
    Yu V. Neonatal sepsis and infection control policies in Australia. J. Paediatr. Child Health 1990; 26: 252256.
  • 6
    Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339343.
  • 7
    Lashkari HP, Chow P, Godambe S. Aqueous 2% chlorhexidine-induced chemical burns in an extremely premature infant. Arch. Dis. Child Fetal Neonatal Ed. 2012; 97: F64.